Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-5 (2020)
Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent Mycoplasma pneumoniae. To date VED has prevented development of an efficacious vaccine against this significant human respiratory pathogen. Herein we
Autor:
Soiba Khalid Mansoor, Laurel O. Sillerud, Judy L. Cannon, David S. Peabody, Fadi A. Jamaleddin Ahmad, Jonathan L. Brigman, Erin Crossey, Kiran Bhaskar, Yirong Yang, Amanda Yaney, Julianne Peabody, Bryce Chackerian, Colin M. Wilson, Maria Alvarez, Nicole Maphis, Shanya Jiang, Reed Selwyn
Publikováno v:
npj Vaccines, Vol 4, Iss 1, Pp 1-13 (2019)
NPJ Vaccines
NPJ Vaccines
Tauopathies, including frontotemporal dementia (FTD) and Alzheimer’s disease (AD) are progressive neurodegenerative diseases clinically characterized by cognitive decline and could be caused by the aggregation of hyperphosphorylated pathological ta
Autor:
Charles A. Scanga, Mario Roederer, JoAnne L. Flynn, Mark Rodgers, Pauline Maiello, Joshua A Hackney, Thomas Lindenstrøm, Amy J. Myers, Victor Prikhodko, Dominick Laddy, Hannah P. Gideon, Patricia A. Darrah, Philana Ling Lin, Robert M. DiFazio, Peter Andersen, Thomas J. Evans, Robert A. Seder
Publikováno v:
npj Vaccines, Vol 4, Iss 1, Pp 1-13 (2019)
NPJ Vaccines
NPJ Vaccines
Tuberculosis (TB) is the leading cause of death from infection worldwide. The only approved vaccine, BCG, has variable protective efficacy against pulmonary TB, the transmissible form of the disease. Therefore, improving this efficacy is an urgent pr